Explore

Capbase

Senti Biosciences Holdings, Inc. — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Biotechnology

$10MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

Senti Biosciences Holdings, Inc. filed a Form D notice of exempt offering with the SEC.

1 rounds

1 round · latest Private placement (Form D), May 2026 · $10M raised

No investors recorded yet for Senti Biosciences Holdings, Inc..

Leadership

Timothy LuExecutive Officer · Chief Executive Officer of each Issuer and Director of Senti Biosciences Holdings, Inc.Since 2026Source: [SEC]

Edward MathersDirector · Director of Senti Biosciences Holdings, Inc.Since 2026Source: [SEC]

Senti Biosciences Holdings, Inc. has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for Senti Biosciences Holdings, Inc..

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Stage

Series A

Sector

Healthcare